PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 80-90% of SAVA's 69.77. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.10
Environmental score 80-90% of SAVA's 70.06. Walter Schloss would scrutinize carbon exposure and transition planning.
59.22
Social score 90-95% of SAVA's 63.86. Bill Ackman would demand clear social improvement catalysts.
59.26
Governance score below 80% of SAVA's 75.39. Jim Chanos would check for potential agency conflicts and oversight failures.